Cargando…
Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background. The complementary and alternative medicines in treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) are controversial. Methods. We searched PubMed, Ovid Embase, Web of Science, Cochrane Library databases, CNKI, Wanfang Database, CBM, VIP, and AMED for randomized controlled...
Autores principales: | Tang, Bozong, Zhang, Jianliang, Yang, Zongguo, Lu, Yunfei, Xu, Qingnian, Chen, Xiaorong, Lin, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884811/ https://www.ncbi.nlm.nih.gov/pubmed/27293460 http://dx.doi.org/10.1155/2016/5105108 |
Ejemplares similares
-
Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
por: Lin, Xianwei, et al.
Publicado: (2019) -
Moxibustion for diarrhea-predominant irritable bowel syndrome: A protocol for systematic review and network meta-analysis
por: Dong, Tiantian, et al.
Publicado: (2021) -
Moxibustion treatment for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial
por: Bao, Chunhui, et al.
Publicado: (2016) -
Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials
por: Yang, Zongguo, et al.
Publicado: (2017) -
Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis
por: Yang, Zongguo, et al.
Publicado: (2016)